The Expression and Clinical Significance of CA125, CEA and CYFRA21-1 in the Treatment of Advanced Non-small Cell Lung Cancer with Bevacizumab Combined with TP Chemotherapy

doi:10.11748/bjmy.issn.1006-1703.2018.06.021

PDF(3572 KB)

Labeled Immunoassays and Clinical Medicine ›› 2018, Vol. 25 ›› Issue (6) : 834-838. DOI: 10.11748/bjmy.issn.1006-1703.2018.06.021

The Expression and Clinical Significance of CA125, CEA and CYFRA21-1 in the Treatment of Advanced Non-small Cell Lung Cancer with Bevacizumab Combined with TP Chemotherapy

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2018, 25(6): 834-838 https://doi.org/10.11748/bjmy.issn.1006-1703.2018.06.021

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(3572 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2017-11-23	2018-01-05	2018-06-20
Issue Date
2019-01-31

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS